Institutional Ownership Ascendis Pharma A/S (ASND)
This table provides information about the institutional ownership of Ascendis Pharma A/S (ASND). We have compiled data on the 318 institutions that hold shares in the stock, with a total of 65 Million shares, which have been reported (via 13F filing form) to have a value of $13.3 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
66,215
shares
|
$13.5 Million
0.01% of portfolio
|
Q3 2025
Added 13.67%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
61,538
shares
|
$12.6 Million
0.0% of portfolio
|
Q3 2025
Added 5.73%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 13, 2025 Q3 2025 |
60,658
shares
|
$12.4 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2025 Q3 2025 |
60,000
shares
|
$12.3 Million
0.91% of portfolio
|
Q3 2025
New holding
|
|
|
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
Frankfurt Am Main, 2M |
Nov 14, 2025 Q3 2025 |
53,730
shares
|
$11 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Silverarc Capital Management, LLC
|
Nov 12, 2025 Q3 2025 |
53,554
shares
|
$10.9 Million
2.19% of portfolio
|
Q3 2025
Reduced 38.13%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
52,500
shares
|
$10.7 Million
2.94% of portfolio
|
Q3 2024
Reduced 39.46%
|
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
51,080
shares
|
$10.4 Million
10.47% of portfolio
|
Q3 2025
New holding
|
|
|
Abrdn PLC
|
Nov 06, 2025 Q3 2025 |
49,426
shares
|
$10.1 Million
0.02% of portfolio
|
Q3 2025
Reduced 64.6%
|
|
|
Diversified Trust CO
|
Oct 20, 2025 Q3 2025 |
45,681
shares
|
$9.34 Million
0.23% of portfolio
|
Q3 2025
Added 0.58%
|
|
|
Castleark Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
42,656
shares
|
$8.72 Million
0.28% of portfolio
|
Q3 2025
New holding
|
|
|
Lazard Asset Management LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
41,731
shares
|
$8.53 Million
0.01% of portfolio
|
Q3 2025
Reduced 20.71%
|
|
|
Russell Investments Group, Ltd.
|
Nov 13, 2025 Q3 2025 |
41,459
shares
|
$8.47 Million
0.01% of portfolio
|
Q3 2025
Added 41.18%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
40,343
shares
|
$8.25 Million
1.0% of portfolio
|
Q3 2025
Reduced 4.19%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
38,250
shares
|
$7.82 Million
0.05% of portfolio
|
Q3 2025
Added 1944.36%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
36,345
shares
|
$7.43 Million
0.68% of portfolio
|
Q3 2025
Added 2492.37%
|
|
|
Empowered Funds, LLC
|
Nov 13, 2025 Q3 2025 |
36,077
shares
|
$7.37 Million
0.08% of portfolio
|
Q3 2025
Added 8.68%
|
|
|
Jain Global LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
35,962
shares
|
$7.35 Million
0.04% of portfolio
|
Q3 2025
New holding
|
|
|
Schroder Investment Management Group
London, X0 |
Nov 12, 2025 Q3 2025 |
33,391
shares
|
$6.83 Million
0.01% of portfolio
|
Q3 2025
Reduced 41.41%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Nov 14, 2025 Q3 2025 |
33,177
shares
|
$6.78 Million
1.79% of portfolio
|
Q3 2025
Reduced 54.35%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
32,900
shares
|
$6.72 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Voleon Capital Management LP
Berkeley, CA |
Nov 14, 2025 Q3 2025 |
31,926
shares
|
$6.53 Million
0.16% of portfolio
|
Q3 2025
New holding
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
31,670
shares
|
$6.47 Million
0.0% of portfolio
|
Q3 2025
Added 0.57%
|
|
|
Capital International Sarl
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
30,862
shares
|
$6.31 Million
0.11% of portfolio
|
Q3 2025
Added 9.59%
|
|
|
Troluce Capital Advisors LLC
Dorado, PR |
Nov 14, 2025 Q3 2025 |
30,000
shares
|
$6.13 Million
1.12% of portfolio
|
Q2 2025
New holding
|
|